Status:
COMPLETED
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
Lead Sponsor:
AstraZeneca
Conditions:
Left Ventricle Function
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
To explore if AZD1305 compromises left ventricular performance in patients with left ventricular dysfunction
Eligibility Criteria
Inclusion
- Male patients and postmenopausal women
- Mildly/moderately decreased heart function
- Regular heart rhythm
Exclusion
- Potassium outside normal reference values
- Child bearing potential
- Severely decreased heart function
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00748982
Start Date
August 1 2008
End Date
July 1 2009
Last Update
June 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Gothenburg, Sweden